Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13401-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13401-1-AP, RRID:AB_10642958
- Product name
- PAQR4 antibody
- Antibody type
- Polyclonal
- Description
- PAQR4 antibody (Cat. #13401-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4.
LINC00162 regulates cell proliferation and apoptosis by sponging PAQR4-targeting miR-485-5p.
PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway.
Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis.
PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation.
Wang W, Huang Q, Liao Z, Zhang H, Liu Y, Liu F, Chen X, Zhang B, Chen Y, Zhu P
Experimental hematology & oncology 2023 Jan 6;12(1):1
Experimental hematology & oncology 2023 Jan 6;12(1):1
VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4.
Shi X, Zhao P, Zhao G
Cancer gene therapy 2023 Feb;30(2):256-266
Cancer gene therapy 2023 Feb;30(2):256-266
LINC00162 regulates cell proliferation and apoptosis by sponging PAQR4-targeting miR-485-5p.
Lee WJ, Ji H, Jeong SD, Pandey PR, Gorospe M, Kim HH
Journal of cellular physiology 2022 Jul;237(7):2943-2960
Journal of cellular physiology 2022 Jul;237(7):2943-2960
PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway.
Zhao G, Shi X, Sun Z, Zhao P, Lu Z
Acta biochimica et biophysica Sinica 2021 Dec 8;53(12):1602-1613
Acta biochimica et biophysica Sinica 2021 Dec 8;53(12):1602-1613
Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis.
Chen W, Cen S, Zhou X, Yang T, Wu K, Zou L, Luo J, Li C, Lv D, Mao X
Frontiers in cell and developmental biology 2020;8:624764
Frontiers in cell and developmental biology 2020;8:624764
PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation.
Xu P, Jiang L, Yang Y, Wu M, Liu B, Shi Y, Shen Q, Jiang X, He Y, Cheng D, Xiong Q, Yang Z, Duan L, Lin J, Zhao S, Shi P, Yang C, Chen Y
Theranostics 2020;10(8):3767-3778
Theranostics 2020;10(8):3767-3778
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PAQR4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PAQR4. This antibody recognizes human, mouse, rat antigen. The PAQR4 antibody has been validated for the following applications: ELISA, WB analysis.
